These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16899201)

  • 1. Update on toll-like receptor ligands and allergy: implications for immunotherapy.
    Horner AA
    Curr Allergy Asthma Rep; 2006 Sep; 6(5):395-401. PubMed ID: 16899201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on toll-like receptor-directed therapies for human disease.
    Tse K; Horner AA
    Ann Rheum Dis; 2007 Nov; 66 Suppl 3(Suppl 3):iii77-80. PubMed ID: 17934102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Airway peptidoglycan and immunostimulatory DNA exposures have divergent effects on the development of airway allergen hypersensitivities.
    Chisholm D; Libet L; Hayashi T; Horner AA
    J Allergy Clin Immunol; 2004 Mar; 113(3):448-54. PubMed ID: 15007346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptor ligands and atopy: a coin with at least two sides.
    Horner AA
    J Allergy Clin Immunol; 2006 May; 117(5):1133-40. PubMed ID: 16675343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translational mini-review series on Toll-like receptors: Toll-like receptor ligands as novel pharmaceuticals for allergic disorders.
    Goldman M
    Clin Exp Immunol; 2007 Feb; 147(2):208-16. PubMed ID: 17223960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptors and immune response in allergic disease.
    Gangloff SC; Guenounou M
    Clin Rev Allergy Immunol; 2004 Apr; 26(2):115-25. PubMed ID: 15146108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLR9-based immunotherapy for the treatment of allergic diseases.
    Farrokhi S; Abbasirad N; Movahed A; Khazaei HA; Pishjoo M; Rezaei N
    Immunotherapy; 2017 Mar; 9(4):339-346. PubMed ID: 28303762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptors as targets for allergen immunotherapy.
    Aryan Z; Rezaei N
    Curr Opin Allergy Clin Immunol; 2015 Dec; 15(6):568-74. PubMed ID: 26418475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunobiology of toll-like receptors in allergic disease.
    Bauer S; Hangel D; Yu P
    Immunobiology; 2007; 212(6):521-33. PubMed ID: 17544836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunostimulatory oligonucleotides in therapy of allergic diseases.
    Lazarczyk M; Grzela K; Grzela T
    Expert Opin Biol Ther; 2005 Apr; 5(4):525-36. PubMed ID: 15934830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of aeroallergen immunity by the innate immune system: laboratory evidence for a new paradigm.
    Horner AA
    J Innate Immun; 2010; 2(2):107-13. PubMed ID: 20375629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of Toll-like receptors in the pathogenesis of allergic diseases - where is the truth?].
    Dębińska A; Boznański A
    Postepy Hig Med Dosw (Online); 2014 Mar; 68():230-7. PubMed ID: 24662791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production.
    Gill N; Deacon PM; Lichty B; Mossman KL; Ashkar AA
    J Virol; 2006 Oct; 80(20):9943-50. PubMed ID: 17005672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Toll' gates for future immunotherapy.
    Ishii KJ; Uematsu S; Akira S
    Curr Pharm Des; 2006; 12(32):4135-42. PubMed ID: 17100616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLR9-based immunotherapy for allergic disease.
    Hayashi T; Raz E
    Am J Med; 2006 Oct; 119(10):897.e1-6. PubMed ID: 17000223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing the Safety and Efficacy of Food Allergy Immunotherapy: a Review of Adjunctive Therapies.
    Virkud YV; Wang J; Shreffler WG
    Clin Rev Allergy Immunol; 2018 Oct; 55(2):172-189. PubMed ID: 29968170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Responses with participation of toll-like receptors in protective immunity and in pathologic states].
    Skivka LM; Pozur VV
    Ukr Biokhim Zh (1999); 2008; 80(3):5-20. PubMed ID: 18959023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cells and toll-like receptors in allergy and asthma.
    Duez C; Gosset P; Tonnel AB
    Eur J Dermatol; 2006; 16(1):12-6. PubMed ID: 16436336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presymptomatic differences in Toll-like receptor function in infants who have allergy.
    Prescott SL; Noakes P; Chow BW; Breckler L; Thornton CA; Hollams EM; Ali M; van den Biggelaar AH; Tulic MK
    J Allergy Clin Immunol; 2008 Aug; 122(2):391-9, 399.e1-5. PubMed ID: 18571707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining a role for ambient TLR ligand exposures in the genesis and prevention of allergic diseases.
    Tse K; Horner AA
    Semin Immunopathol; 2008 Feb; 30(1):53-62. PubMed ID: 17989979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.